{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "1827573",
  "DateCompleted": {
    "Year": "1991",
    "Month": "06",
    "Day": "12"
  },
  "DateRevised": {
    "Year": "2015",
    "Month": "11",
    "Day": "23"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "jpn"
    ],
    "ELocationID": [],
    "Journal": {
      "ISSN": "0385-0684",
      "JournalIssue": {
        "Volume": "18",
        "Issue": "6",
        "PubDate": {
          "Year": "1991",
          "Month": "May"
        }
      },
      "Title": "Gan to kagaku ryoho. Cancer & chemotherapy",
      "ISOAbbreviation": "Gan To Kagaku Ryoho"
    },
    "ArticleTitle": "[5-Fluorouracil level and pyrimidine nucleoside phosphorylase activity in cancer patients after oral administration of doxifluridine (5'-DFUR)].",
    "Pagination": {
      "StartPage": "965",
      "EndPage": "969",
      "MedlinePgn": "965-9"
    },
    "Abstract": {
      "AbstractText": [
        "For the purpose to evaluate the distribution of 5'-DFUR in the cancerous tissues and non-cancerous tissues of 64 cancer patients (21 gastric, 25 colo-rectal and 18 breast cancers), pyrimidine nucleoside phosphorylase (PyNPase) activity and 5-FU level were determined by bioassay and GC-MS method. 5-FU levels in the plasma were also measured in all patients. Four hundred mg of 5'-DFUR was orally administrated three times a day for 3 to 7 days and just 3 hours before surgical operations. PyNPase activity and 5-FU level were significantly higher in the cancerous tissues than non-cancerous ones. 5-FU levels in the plasma were significantly lower than those in both cancerous and non-cancerous tissues. In conclusion, 5'-DFUR is expected to be an useful anticancer drug because of the selective accumulation of converted 5-FU in cancerous tissues."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Dept. of Surgery II, Nagasaki Univ. School of Medicine, Japan."
          }
        ],
        "LastName": "Maeda",
        "ForeName": "H",
        "Initials": "H"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Miyamoto",
        "ForeName": "T",
        "Initials": "T"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Mochinaga",
        "ForeName": "N",
        "Initials": "N"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Tsunoda",
        "ForeName": "T",
        "Initials": "T"
      }
    ],
    "PublicationTypeList": [
      "English Abstract",
      "Journal Article"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "Japan",
    "MedlineTA": "Gan To Kagaku Ryoho",
    "NlmUniqueID": "7810034",
    "ISSNLinking": "0385-0684"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "039LU44I5M",
      "NameOfSubstance": "Floxuridine"
    },
    {
      "RegistryNumber": "EC 2.4.2.-",
      "NameOfSubstance": "Pentosyltransferases"
    },
    {
      "RegistryNumber": "EC 2.4.2.-",
      "NameOfSubstance": "Pyrimidine Phosphorylases"
    },
    {
      "RegistryNumber": "U3P01618RT",
      "NameOfSubstance": "Fluorouracil"
    },
    {
      "RegistryNumber": "V1JK16Y2JP",
      "NameOfSubstance": "doxifluridine"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "drug therapy",
        "metabolism"
      ],
      "DescriptorName": "Adenocarcinoma"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Administration, Oral"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Adult"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Aged"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Aged, 80 and over"
    },
    {
      "QualifierName": [
        "drug therapy",
        "metabolism"
      ],
      "DescriptorName": "Breast Neoplasms"
    },
    {
      "QualifierName": [
        "drug therapy",
        "metabolism"
      ],
      "DescriptorName": "Colonic Neoplasms"
    },
    {
      "QualifierName": [
        "drug effects"
      ],
      "DescriptorName": "Enzyme Activation"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Female"
    },
    {
      "QualifierName": [
        "administration & dosage",
        "pharmacokinetics"
      ],
      "DescriptorName": "Floxuridine"
    },
    {
      "QualifierName": [
        "analysis"
      ],
      "DescriptorName": "Fluorouracil"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Male"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Middle Aged"
    },
    {
      "QualifierName": [
        "metabolism"
      ],
      "DescriptorName": "Pentosyltransferases"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Pyrimidine Phosphorylases"
    },
    {
      "QualifierName": [
        "drug therapy",
        "metabolism"
      ],
      "DescriptorName": "Stomach Neoplasms"
    }
  ]
}